However, since in humans with Alzheimer’s disease the amyloid or tau lesions occur before cognitive alterations, cerebral atrophy or neuronal loss [47], we expected to detect stronger β-amyloid and/or tau lesions in lemurs that displayed clinical signs. This evidence concerns the gene MAPT and Alzheimer disease.